Elbasvir and Grazoprevir
- Generic Name
- Elbasvir and Grazoprevir
- Indication
适用于治疗基因1、4型慢性丙肝的成年患者。
Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 62
- Registration Number
- NCT02743897
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)
Phase 2
Completed
- Conditions
- Chronic Hepatitis C
- Interventions
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02115321
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath